Use of mammography with contrast for the diagnosis of breast cancer
1 MD. Radiologist, Universidad de Mariano Galvez de Guatemala.
2 4th Year Radiology Resident, Pontificia Universidad católica do Rio de Janeiro, Brazil.
3 Third Year Radiology Resident, Universidad Mariano Gálvez, Guatemala.
4 General Physician, Universidad El Bosque, Bogotá.
5 General Physician, Universidad del Cauca, Colombia.
6 General Physician, Corporación Universitaria Remington, Colombia.
Review Article
World Journal of Advanced Research and Reviews, 2022, 14(01), 277–283
Article DOI: 10.30574/wjarr.2022.14.1.0315
Publication history:
Received on 07 March 2022; revised on 14 April 2022; accepted on 16 April 2022
Abstract:
Breast cancer is a heterogeneous disease, caused by the progressive accumulation of mutations and chromosomal abnormalities. Currently, breast cancer is considered the neoplasm with the highest incidence and mortality in women worldwide, so much so that every year in the world, one million breast cancers are discovered and around 400,000 women die from it. The search for diagnostic techniques that allow the detection of this pathology in an effective way has become essential and that is where mammography emerges, as a screening method, which has been shown to reduce mortality by detecting breast cancer early; however, in very dense breasts detection is difficult, so they have been modified, and thus generating new screening and diagnostic methods such as contrast-enhanced mammography, which is the newest and most promising imaging technique based on neovascularization of breast tumors in a similar way and may even be better than MRI.
Keywords:
Breast Cancer; Diagnosis; Mammography; Contrast
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0